Amgen Q3 Adj. EPS $4.67 Beats $4.27 Estimate, Sales $6.70B Beat $6.68B Estimate

Amgen (NASDAQ:AMGN) reported quarterly earnings of $4.67 per share which beat the analyst consensus estimate of $4.27 by 9.37 percent. This is a 6.86 percent increase over earnings of $4.37 per share from the same period last year. The company reported quarterly sales of $6.70 billion which beat the analyst consensus estimate of $6.68 billion by 0.30 percent. This is a 4.31 percent increase over sales of $6.42 billion the same period last year.